{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:31:39Z","timestamp":1772908299045,"version":"3.50.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lunbeck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10286-017-0434-6","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T14:13:09Z","timestamp":1499091189000},"page":"29-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease"],"prefix":"10.1007","volume":"27","author":[{"given":"Daniel","family":"Kremens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent P.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"434_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10286-016-0349-7","volume":"26","author":"A Elgebaly","year":"2016","unstructured":"Elgebaly A, Abdelazeim B, Mattar O, Gadelkarim M, Salah R, Negida A (2016) Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 26:171\u2013180","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"434_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","volume":"26","author":"A Fanciulli","year":"2016","unstructured":"Fanciulli A, Gobel G, Ndayisaba JP, Granata R, Duerr S, Strano S, Colosimo C, Poewe W, Pontieri FE, Wenning GK (2016) Supine hypertension in Parkinson\u2019s disease and multiple system atrophy. Clin Auton Res Off J Clin Auton Res Soc 26:97\u2013105","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"434_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G (2015) Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B). Mov Disord Off J Mov Disord Soc 30:646\u2013654","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"434_CR4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA (2015) Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovas Ther 13:875\u2013891","journal-title":"Expert Rev Cardiovas Ther"},{"key":"434_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10286-016-0363-9","volume":"26","author":"W Smith","year":"2016","unstructured":"Smith W, Wan H, Much D, Robinson AG, Martin P (2016) Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study. Clin Auton Res Off J Clin Auton Res Soc 26:269\u2013277","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"434_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","volume":"26","author":"T Umehara","year":"2016","unstructured":"Umehara T, Matsuno H, Toyoda C, Oka H (2016) Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res Off J Clin Auton Res Soc 26:15\u201321","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-017-0434-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-017-0434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-017-0434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T11:28:29Z","timestamp":1502969309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-017-0434-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":6,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s10286-017-0434-6","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}